ARYL, HETEROARYL, AND HETEROCYCLIC PHARMACEUTICAL COMPOUNDS FOR TREATMENT OF MEDICAL DISORDERS

To provide complement factor D inhibitors, pharmaceutical compositions and uses thereof, as well as processes for manufacture thereof.SOLUTION: Compounds provided include compounds represented by specific formulas shown in the figure, or a pharmaceutically acceptable salt, a prodrug, an isotopic ana...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: HASHIMOTO TERUHIRO, WANG QIUPING, CHEN DAWEI, JOEL CHARLES BARRISH, GODWIN PAIS, JASON ALLAN WILES, AVINASH S PHADKE, WANG XIANGZHU, MILIND DESHPANDE, ATUL AGARWAL, KYLE J EASTMAN, WILLIAM GREENLEE, VENKAT RAO GADHACHANDA
Format: Patent
Sprache:eng ; jpn
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:To provide complement factor D inhibitors, pharmaceutical compositions and uses thereof, as well as processes for manufacture thereof.SOLUTION: Compounds provided include compounds represented by specific formulas shown in the figure, or a pharmaceutically acceptable salt, a prodrug, an isotopic analog, N-oxide or an isolated isomer thereof, optionally in a pharmaceutically acceptable composition. Specifically, the compounds in the figure are presented, for example. Inhibitors described herein target a Factor D and inhibit or regulate a complement cascade.SELECTED DRAWING: Figure 19 【課題】補体D因子阻害剤、その医薬組成物及び使用、並びにそれらの製造プロセスを提供する。【解決手段】提供される化合物には、任意に薬学的に許容可能な組成物中の図に示す特定の式で表される化合物、又はその薬学的に許容可能な塩、プロドラッグ、同位体アナログ、N-オキシド若しくは単離異性体が含まれる。具体的には、例えば下記の化合物が示される。本明細書に記載の阻害剤は、D因子を標的とし、補体カスケードを阻害又は調節する。TIFF2024023337000761.tif60169【選択図】図19